Opendata, web and dolomites

ClarifyLupus

Launching the Breakthrough in Lupus Diagnostics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ClarifyLupus project word cloud

Explore the words cloud of the ClarifyLupus project. It provides you a very rough idea of what is the project "ClarifyLupus" about.

stages    letter    disruption    business    damages    methodology    diagnosis    13    perform    conducting    lupus    mass    blood    patients    biomarker    difficulty    lives    clarifylupus    later    acceleration    autoimmune    proteins    expert    passed    rule    altered    diagnosed    jo    recruiting    clinical    earlier    confirm    2018    autoantibodies    symptoms    6m    lab    egas    members    diagnostic    stage    usa    spectroscopy    start    unspecific    founded    irreversible    stating    hospital    unavailability    people    samples    quantifying    clarify    technologists    decades    discovery    atilde    devastating    diseases    play    tested    january    rodrigues    contrast    confounding    toxicology    lisbon    25m    disease    8m    overlapping    competitors    approval    cohitech    april    worse    ethical    portuguese    proof    moniz    diagnosing    occurrence    portugal    assays    until    team    quality    committee    breakthrough    alexandra    onset    2017    secured    market    alone    antunes    analytical    prestigious   

Project "ClarifyLupus" data sheet

The following table provides information about the project.

Coordinator
CLARIFY ANALYTICAL LDA 

Organization address
address: RUA DE MERCADORES 128A
city: EVORA
postcode: 7000-872
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website http://www.clarifyanalytical.pt/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CLARIFY ANALYTICAL LDA PT (EVORA) coordinator 50˙000.00

Map

 Project objective

The difficulty on diagnosing lupus is due not only to the occurrence of overlapping symptoms with other autoimmune diseases but also to the unavailability of a lab test to confirm or rule out Lupus. The autoimmune disease is devastating, and the later it is diagnosed, the worse are the irreversible damages to the patients. In the USA alone, there are 13.8M people with Lupus and overlapping diseases and 2,6M new cases of these diseases are diagnosed each year. These diseases affect more than 25M people in the EU. We have developed a technology capable of identifying and quantifying altered proteins that play a key role in the onset of Lupus. Our product ClarifyLupus is a diagnostic test that is effective since the early stages of the disease. Although our competitors are conducting research on Lupus biomarker discovery, they all are focused in autoantibodies biomarker discovery that are highly unspecific among Lupus-confounding diseases. In contrast we have a Lupus-specific biomarker that enables the Lupus diagnosis much earlier than our competitors. We have passed the proof-of-concept stage where our diagnosis methodology was tested in blood samples and in January 2018 we have secured the Portuguese ethical committee approval to perform clinical assays, and are recruiting 50 patients until the end of the year. In April 2018 we secured a Letter of Support from the Egas Moniz Hospital in Lisbon, stating the importance and market disruption of ClarifyLupus. Clarify Analytical was founded in 2017 by Alexandra Antunes and João Rodrigues, two expert technologists in the fields of toxicology and mass spectroscopy, supported by 3 team members. The start-up was selected for the prestigious CoHiTech acceleration program in Portugal, focused on business and technology go-to-market. ClarifyLupus will be the breakthrough for Lupus diagnosis which will allow Lupus patients to be treated earlier, extending their lives by decades and improving their quality.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLARIFYLUPUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLARIFYLUPUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More  

IRMELI (2019)

AI-BASED BROKERING TECHNOLOGY PLATFORM TO FIND THE PERFECT MATCH BETWEEN THE CUSTOMER AND BANK

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More